Hims, Amazon and Hers

Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. Amazon on Thursday launched the treatments through its One Medical telehealth service,
Hims & Hers drops 22% on Amazon competition concerns (update)
Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment markets through its telehealth unit. Read more here.
BofA double downgrades Hims & Hers on Amazon competition
BofA downgraded Hims & Hers (HIMS) to Underperform from Buy with a price target of $18, down from $32. Amazon (AMZN) launched a cash-pay
Amazon One Medical launches service to compete with Hims & Hers
The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five conditions including erectile dysfunction and men’s hair loss.
Amazon One Medical rolls out telehealth treatment services in competition with Ro, Hims & Hers
Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care. | Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care.
Amazon launches fixed pricing to treat conditions like hair loss. Hims & Hers stock drops 15%
Amazon announced Prime members can access new upfront pricing to treat five common conditions like erectile disfunction and men's hair loss.
Hims & Hers drops 17% as Amazon rolls out expanded telehealth service
Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 17% in morning trading Thursday after Amazon (NASDAQ:AMZN) announced it was launching an expanded pay-per-visit telehealth service,
These Stocks Moved the Most Today: Walt Disney, Super Micro, Cisco, ASML, JD.com, Tapestry, Intuitive Machines, Hims & Hers, and More
Walt Disney’s earnings beat Wall Street estimates, Super Micro Computer extends losses, and Cisco posts fiscal first-quarter ...
Amazon Gets Into the Boner Pill Business, Hims Stock Goes Limp
Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon Pharmacy.
Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new ...
Becker's Hospital Review1h
Hims & Hers launches GLP-1 tracker amid shortages
Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.
Hims & Hers falls -17.7%
Hims & Hers (HIMS) is down -17.7%, or -$4.88 to $22.72. Published first on TheFly – the ultimate source for real-time, ...
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Hims & Hers once again delivered a blowout quarter with surging revenue. Revenue soared 77% year over year to $401.6 million, ...
AOL1d
What's Going On With Hims & Hers Health Stock On Wednesday?
Health and wellness platform Hims & Hers Health, Inc. (NYSE:HIMS), which has gained traction for its obesity-related ...
Stocktwits on MSN6h
Hims & Hers Stock’s Retail Army Brushes Off Amazon Medical One’s Rival Service Even As Citi Sees Threat
Shares of Hims & Hers ($HIMS) plummeted nearly 15% on Thursday after Amazon.com, Inc. ($AMZN) launched its new Amazon One ...